Dornase

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 450 publications

Sustained neutrophil extracellular traps cause fracture nonunion.

Sustained neutrophil extracellular traps cause fracture nonunion.

Journal: Science translational medicine

Published: September 02, 2026

Pancreatopleural Fistula Presenting as Recurrent Right-Sided Pleural Effusion: A Case Report.

Pancreatopleural Fistula Presenting as Recurrent Right-Sided Pleural Effusion: A Case Report.

Journal: Cureus

Published: July 10, 2026

C5a-C5aR1 axis activation drives neutrophil extracellular trap formation in SARS-CoV-2 N protein-mediated acute kidney injury.

C5a-C5aR1 axis activation drives neutrophil extracellular trap formation in SARS-CoV-2 N protein-mediated acute kidney injury.

Journal: Biochemical and biophysical research communications

Published: July 09, 2026

Intrapleural Tissue Plasminogen Activator With or Without Dornase Alfa: A Multicenter Retrospective Cohort Study.

Intrapleural Tissue Plasminogen Activator With or Without Dornase Alfa: A Multicenter Retrospective Cohort Study.

Journal: Hospital pharmacy

Published: July 03, 2026

Extracellular traps from myeloid cells as therapeutic targets in traumatic heterotopic ossification.

Extracellular traps from myeloid cells as therapeutic targets in traumatic heterotopic ossification.

Journal: Science translational medicine

Published: May 06, 2026

Characterizing Bronchoscopy in Pediatric Critical Care: A Cohort Analysis of Practice and Outcomes.

Characterizing Bronchoscopy in Pediatric Critical Care: A Cohort Analysis of Practice and Outcomes.

Journal: Journal of intensive care medicine

Published: April 09, 2026

Real-world efficacy, safety and heterogenicity of efficacy of elexacaftor-tezacaftor-ivacaftor in younger children (6-11 years old) with cystic fibrosis.

Real-world efficacy, safety and heterogenicity of efficacy of elexacaftor-tezacaftor-ivacaftor in younger children (6-11 years old) with cystic fibrosis.

Journal: Respiratory medicine

Published: April 06, 2026

Real-world Efficacy, Safety and Heterogenicity of Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in Younger Children (6-11 Years Old) with Cystic Fibrosis.

Real-world Efficacy, Safety and Heterogenicity of Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in Younger Children (6-11 Years Old) with Cystic Fibrosis.

Journal: Respiratory medicine

Published: April 06, 2026

Extended Intrapleural Tissue Plasminogen Activator (tPA)-Dornase Alfa (DNase) Therapy Beyond the Standard Multicenter Intrapleural Sepsis Trial 2 (MIST-2) Regimen in a High-Risk Patient With Complex Empyema: A Case Report.

Extended Intrapleural Tissue Plasminogen Activator (tPA)-Dornase Alfa (DNase) Therapy Beyond the Standard Multicenter Intrapleural Sepsis Trial 2 (MIST-2) Regimen in a High-Risk Patient With Complex Empyema: A Case Report.

Journal: Cureus

Published: March 28, 2026

2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of tPa and DNase or tPa Alone for Fibrinolysis.

2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of tPa and DNase or tPa Alone for Fibrinolysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 27, 2026

Airway Mucosal Defense: Mucins, Innate Immunity, and Contemporary Mucoactive Strategies.

Airway Mucosal Defense: Mucins, Innate Immunity, and Contemporary Mucoactive Strategies.

Journal: Biomedicines

Published: February 17, 2026

Effect of discontinuation and reduction of respiratory cotherapies on the effectiveness of CFTR modulators.

Effect of discontinuation and reduction of respiratory cotherapies on the effectiveness of CFTR modulators.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: February 10, 2026

Showing 1-12 of 450

Last Updated: 09/26/2026